ABBOTT LABORATORIES — Director's Dealing 2015

Apr 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-04-27

Reporting Person: BIRD ROGER (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-27	Common shares without par value	M	13527	$21.2194	Acquired	55537	Direct
2015-04-27	Common shares without par value	M	10821	$25.2461	Acquired	66358	Direct
2015-04-27	Common shares without par value	S	100	$47.5750	Disposed	66258	Direct
2015-04-27	Common shares without par value	S	300	$47.57	Disposed	65958	Direct
2015-04-27	Common shares without par value	S	5953	$47.5710	Disposed	60005	Direct
2015-04-27	Common shares without par value	S	11195	$47.5610	Disposed	48810	Direct
2015-04-27	Common shares without par value	S	500	$47.5620	Disposed	48310	Direct
2015-04-27	Common shares without par value	S	900	$47.57	Disposed	47410	Direct
2015-04-27	Common shares without par value	S	5400	$47.56	Disposed	42010	Direct
2015-04-27	Common shares without par value	S	2866	$47.57	Disposed	39144	Direct
2015-04-27	Common shares without par value	S	1334	$47.58	Disposed	37810	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-27	Option (right to buy)	$21.2194	M	13527	Disposed	2016-02-16	Common shares (13527)	Direct
2015-04-27	Option (right to buy)	$25.2461	M	10821	Disposed	2017-02-15	Common shares (10821)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.